
1. General Information
Basaglar Cart 3 mL contains insulin glargine, a long-acting insulin analogue. It provides a relatively steady insulin effect over an extended period and is generally used as basal (background) insulin therapy for diabetes. It should be used only according to the prescribed treatment plan.
Manufacturer/brand: BASAGLAR
Active ingredient: Insulin glargine
Strength: 100 units/mL
Pack size: 3 mL cartridge = 300 units
Route: Subcutaneous injection
Therapeutic class: Long-acting insulin
2. Product Information
Basaglar 100 units/mL is supplied as a clear insulin solution. A 3 mL cartridge contains 300 units of insulin glargine. Lilly's product information lists 3 mL cartridges for use with its reusable insulin pens, while the BASAGLAR KwikPen is a separate 3 mL prefilled-pen presentation.
The formulation contains insulin glargine along with inactive ingredients including glycerin, metacresol, zinc oxide and water for injection.
3. Uses of Basaglar
Basaglar is prescribed to help control high blood glucose in diabetes by providing background insulin. It may be part of an overall diabetes treatment plan that can also include diet, physical activity, blood-glucose monitoring and other diabetes medicines or mealtime insulin when prescribed.
4. Benefits
When appropriately prescribed and used, Basaglar can:
- Provide long-acting basal insulin coverage.
- Help lower elevated blood-glucose levels.
- Support better overall blood-glucose control.
- Help replace or supplement the insulin that the body does not produce adequately.
- Provide a consistent background insulin effect as part of an individualized diabetes-management plan.
The dose and treatment schedule must be individualized by a healthcare professional.
5. Side Effects
The most important potential adverse effect of insulin therapy is hypoglycemia (low blood sugar). Other possible reactions include injection-site reactions, allergic reactions, skin changes at injection sites, and changes in body weight.
Seek urgent medical attention for severe hypoglycemia, severe allergic symptoms, or other serious reactions.
6. Common Side Effects
Possible side effects include:
- Low blood sugar (hypoglycemia)
- Injection-site redness, swelling, itching or discomfort
- Skin changes or lumps at repeated injection sites
- Weight gain
- Peripheral edema (swelling), which can occur with insulin therapy
Rotating injection sites can help reduce skin changes and improve consistent insulin absorption.
7. How to Use
Basaglar should be administered subcutaneously, using the compatible insulin-delivery device and technique demonstrated by a healthcare professional.
General precautions include:
- Check the medicine and packaging before use.
- Use only the prescribed dose.
- Inject into an appropriate subcutaneous site as instructed.
- Rotate injection sites regularly.
- Do not share the insulin pen or cartridge with another person.
- Use a new compatible needle for each injection.
- Monitor blood glucose according to your healthcare professional's instructions.
Do not change the dose, timing or insulin product yourself. The FDA instructions specifically warn against sharing a BASAGLAR pen, even when the needle has been changed.
8. How Basaglar Works
Basaglar contains insulin glargine, which acts similarly to naturally occurring insulin. It helps glucose move from the bloodstream into tissues where it can be used for energy and helps reduce excessive glucose production by the liver.
Because insulin glargine is formulated as a long-acting insulin, it provides basal insulin activity rather than being intended as a rapid mealtime insulin.
9. Safety Advice
- Use Basaglar only under medical supervision.
- Do not use it to treat diabetic ketoacidosis.
- Do not inject it intravenously or intramuscularly.
- Do not use it during an episode of hypoglycemia until the low blood sugar has been appropriately treated and your healthcare professional has advised you regarding insulin use.
- Monitor blood glucose regularly.
- Tell your doctor about all other medicines you take because some medicines can affect blood-glucose control.
- Rotate injection sites to help prevent lipodystrophy or lumps.
- Store the product according to the manufacturer's instructions and check the expiry date.
- Keep insulin away from unauthorized users and children.
- Never share insulin cartridges or injection devices.
10. FAQs
Q1. What is Basaglar Cart 3 mL?
Basaglar Cart 3 mL is a cartridge containing insulin glargine 100 units/mL, a long-acting insulin. One 3 mL cartridge contains 300 units.
Q2. What is Basaglar used for?
It is used as basal insulin therapy to help control blood glucose in people with diabetes.
Q3. Is Basaglar a long-acting insulin?
Yes. Insulin glargine is a long-acting insulin used for background insulin coverage.
Q4. Can I change my Basaglar dose myself?
No. Dose adjustments should be made only according to your healthcare professional's instructions.
Q5. Can Basaglar be injected into a vein?
No. Basaglar should not be administered intravenously or intramuscularly.
Q6. Can I share my insulin pen with another person?
No. Insulin pens must never be shared, even if the needle has been replaced.
Q7. What is the most important side effect to watch for?
Hypoglycemia (low blood sugar) is an important risk associated with insulin treatment.
Q8. Is the 3 mL cartridge the same as the BASAGLAR KwikPen?
Not exactly. Both contain 3 mL of BASAGLAR 100 units/mL, but the cartridge is designed for a compatible reusable pen, while the KwikPen is a prefilled disposable pen.
11. Substitute for Basaglar
A suitable substitute should not be selected solely on the basis of the name or strength. Other insulin glargine products or other long-acting insulins may sometimes be considered by a healthcare professional, but they are not automatically interchangeable in every situation.
Examples of long-acting insulin options that a clinician may consider include insulin glargine, insulin detemir, or insulin degludec, depending on the patient's medical needs and local availability. Any switch between insulin products should be supervised by a healthcare professional because dose adjustments and glucose monitoring may be necessary.
12. Keywords
Basaglar Cart 3 mL, Basaglar insulin glargine 100 units/mL, Basaglar 3 mL cartridge, insulin glargine cartridge, long acting insulin, basal insulin, diabetes insulin treatment, insulin glargine 100 IU/mL, Basaglar supplier India, Basaglar exporter India, Basaglar medicine exporter, pharmaceutical exporter Nagpur, insulin medicine exporter India, diabetes medicine supplier, insulin glargine supplier, Basaglar wholesale supplier, Basaglar international supplier, Basaglar pharmaceutical export, diabetes care medicines, insulin cartridge supplier, 3 mL insulin cartridge, insulin glargine export from India, Basaglar export to UK, Basaglar export to USA, Basaglar export to Australia, Basaglar export to Canada, Basaglar export to Singapore, Basaglar export to South Korea, Basaglar export to UAE.
Keywords







